Filing Details

Accession Number:
0001127602-13-029653
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-10-23 14:28:51
Reporting Period:
2013-10-22
Filing Date:
2013-10-23
Accepted Time:
2013-10-23 14:28:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
310142 Sensient Technologies Corp SXT Industrial Organic Chemicals (2860) 390561070
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1199087 Richard Malin 777 East Wisconsin Avenue
Milwaukee WI 53202
Assistant Controller No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-10-22 6,000 $23.00 18,243 No 4 M Direct
Common Stock Acquisiton 2013-10-22 6,000 $18.57 24,243 No 4 M Direct
Common Stock Acquisiton 2013-10-22 1,250 $24.15 25,493 No 4 M Direct
Common Stock Disposition 2013-10-22 13,250 $52.84 12,243 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Disposition 2013-10-22 6,000 $0.00 6,000 $23.00
Common Stock Stock Options (Right to Buy) Disposition 2013-10-22 6,000 $0.00 6,000 $18.57
Common Stock Stock Options (Right to Buy) Disposition 2013-10-22 1,250 $0.00 1,250 $24.15
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2005-12-06 2014-12-06 No 4 M Direct
0 2006-12-01 2015-12-01 No 4 M Direct
0 2007-12-07 2016-12-07 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 4,410 Indirect ESOP
Common Stock 2,340 Indirect Savings Plan
Common Stock 260 Indirect Supplemental Benefit Plan
Footnotes
  1. Exercise of in-the-money stock option that would otherwise expire on 12/6/2014, exempt from Section 16(b) by virtue of Rule 16b-6(b) and Rule 16b-3(d) and (e).
  2. Includes shares of restricted stock held under Issuer's 2002 Stock Option Plan and 2007 Stock Plan (formerly known as the 2007 Restricted Stock Plan), and shares held in a dividend reinvestment plan.
  3. Exercise of in-the-money stock option that would otherwise expire on 12/1/2015, exempt from Section 16(b) by virtue of Rule 16b-6(b) and Rule 16b-3(d) and (e).
  4. Exercise of in-the-money stock option that would otherwise expire on 12/7/2016, exempt from Section 16(b) by virtue of Rule 16b-6(b) and Rule 16b-3(d) and (e).
  5. This amount represents the weighted average sale price for the transactions reported on this line. The actual sale prices ranged from $52.70 to $53.13. The reporting person hereby agrees to provide, upon request by the SEC staff, by the Issuer, or by any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  6. Represents shares held in Issuer's ESOP as of the end of the month immediately preceding this filing.
  7. Represents shares held in Issuer's Savings Plan as of the end of the month immediately preceding this filing.
  8. Represents shares held in Issuer's Supplemental Benefit Plan as of the end of the month immediately preceding this filing.
  9. Original option grant vests in three equal annual installments beginning on the date listed in the "Date Exercisable" column.